NovaMechanics

NovaMechanics is a pioneering research and development SME specializing in cheminformatics, bioinformatics, nanoinformatics, and data-driven scientific solutions. Founded in 2009 and headquartered in Nicosia, Cyprus, with operations in Athens, Greece, the company develops cutting-edge software tools, predictive models, and cloud-based platforms to accelerate drug discovery and materials innovation. Its flagship offerings include the Isalos Analytics Platform, a no-code desktop analytics tool for predictive modeling and machine learning, and the Enalos Cloud Platform, which hosts over 500 validated predictive models for virtual screening, ADMET prediction, and safety assessment. NovaMechanics serves as an outsourced R&D partner for pharmaceutical companies and academic institutions, leveraging AI, machine learning, and multiscale simulations to design novel small molecules and support Safe and Sustainable by Design (SSbD) initiatives.